Results 111 to 120 of about 29,491 (205)

Rational Radionuclide Therapy for Recurrent Meningioma. [PDF]

J Nucl Med
Chen WC, Raleigh DR.
europepmc   +1 more source

Fibroblast activation protein inhibitor radiotheranostics for imaging activated tumor stroma and guiding radionuclide therapy. [PDF]

Front Oncol
Wu H, Liu Z.
europepmc   +1 more source

Optimization of Gravity Infusion Protocols for ¹⁷⁷Lu-DOTATATE Administration in Peptide Receptor Radionuclide Therapy. [PDF]

Pharmaceutics
Grasso S, Varallo A, Gaudieri V, Klain M, Pastore R, Arena S, Oliviero C, Buono M, Manzi D, Schiano R, Nappi C, Totaro P, Bonifacio RR, Cuocolo A, Clemente S.   +14 more
europepmc   +1 more source

¹⁷⁷Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer. [PDF]

Mol Biomed
Santos L, Hrynchak I, Sereno J, Ferreira HRS, Silva M, Fonseca A, Almeida R, Teixeira P, Abrunhosa AJ, Gomes CMF.   +9 more
europepmc   +1 more source

Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates. [PDF]

Front Oncol
Engbers PAM, Nonnekens J, Sabatella M.
europepmc   +1 more source

GATE Monte Carlo evaluation of cellular dosimetry for ¹¹⁹Sb in targeted radionuclide therapy. [PDF]

EJNMMI Phys
Hasnaki A, Chegeni N, Barati B, Divband G, Malekzadeh E.   +4 more
europepmc   +1 more source

Epidermal radionuclide therapy with rhenium-188 in non-melanoma skin cancer: a short narrative review. [PDF]

Front Med (Lausanne)
Castellucci P, Vetrone L, Baraldi C, Dika E, Zagni F, Strigari L, Martínez Albero E, Vega Pérez D, Mirzaei S, Fanti S.   +9 more
europepmc   +1 more source

The 20th International Conference on Radionuclide Therapy (ICRT 2025). [PDF]

World J Nucl Med
Frangos S.
europepmc   +1 more source

Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches. [PDF]

Molecules
Kono Y, Utsunomiya K, Kariya S, Tanigawa N.   +3 more
europepmc   +1 more source

Immunogenic cell death as a mechanism of synergy between sunitinib and ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors. [PDF]

Cell Death Discov
Essler M, Veit N, Müller A, Marinova M, Kreppel B.   +4 more
europepmc   +1 more source